RPT904 Clinical Trials (2026): 1 Studies for Ig-E Mediated Food Allergy
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 RPT904 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Ig-E Mediated Food Allergy) and 100 total planned enrollment. 1 RPT904 clinical trial is actively recruiting at 17 U.S. sites across 15 states. Most recent activity: NCT07220811 (Jan 2028).
Where to Participate: All RPT904 Trial Sites in the U.S. (17 sites across 15 states)
Every actively recruiting RPT904trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AR | Arkansas Children's | Little Rock72202 | NCT07220811 | Map |
| CA | Sean N. Parker Center for Allergy and Asthma Research | Palo Alto94304 | NCT07220811 | Map |
| CO | Asthma & Allergy Associates, P.C. | Colorado Springs80907 | NCT07220811 | Map |
| CO | National Jewish Health | Denver80206 | NCT07220811 | Map |
| DC | Children's National Hospital | Washington D.C.20010 | NCT07220811 | Map |
| FL | University of South Florida | Tampa33613 | NCT07220811 | Map |
| GA | Children's Healthcare of Atlanta - Center for Advanced Pediatrics | Atlanta30329 | NCT07220811 | Map |
| MA | Boston's Children's Hospital | Boston02115 | NCT07220811 | Map |
| MI | University of Michigan | Ann Arbor48109 | NCT07220811 | Map |
| MN | Clinical Research Institute, Inc | Minneapolis55402 | NCT07220811 | Map |
| NY | Northwell Health | Great Neck11021 | NCT07220811 | Map |
| NY | Icahn School of Medicine at Mount Sinai | New York10029 | NCT07220811 | Map |
| NC | University of North Carolina at Chapel Hill Clinical and Translational Research Center( CTRC) | Chapel Hill27599 | NCT07220811 | Map |
| OH | Cincinnati Children's Hospital | Cincinnati45229 | NCT07220811 | Map |
| PA | The Children's Hospital of Philadelphia | Philadelphia19104 | NCT07220811 | Map |
| TN | Vanderbilt University | Nashville37232 | NCT07220811 | Map |
| TX | Texas Children's Hospital | Houston77030 | NCT07220811 | Map |
RPT904 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P2 | 1 | 1 |
Recruiting RPT904 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07220811 | Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy | P2 | Ig-E Mediated Food Allergy | 100 | Oct 2025 |
All RPT904 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07220811 | Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy | P2 | recruiting | 100 | RAPT Therapeutics, Inc. | Oct 2025 |
RPT904 clinical trials: frequently asked questions
- How many RPT904 clinical trials are there?
- 1 RPT904 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are RPT904 clinical trials recruiting in 2026?
- Yes — 1 RPT904 trial is actively recruiting in 2026, with 17 U.S. sites across 15 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is RPT904 being studied for?
- RPT904 is being studied for Ig-E Mediated Food Allergy. The trials are grouped by indication on this page.
- What phase is RPT904 in?
- RPT904 clinical trials span 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors RPT904 clinical trials?
- The lead sponsor across the most RPT904 trials is RAPT Therapeutics, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming RPT904as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: